PDF herunterladen
Am J Perinatol 2003; 20(6): 333-340
DOI: 10.1055/s-2003-42691
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Are Perinatal Risk Factors Helpful in Predicting and Optimizing Treatment Strategies for Transient Hypothyroxinemia in Very-Low-Birth-Weight Infants?

Michelle J. Kantor Herring1 , Kathleen H. Leef2 , Robert G. Locke2,3 , John L. Stefano2,3 , Louis  Bartoshesky3,4 , David A. Paul2,3
  • 1Department of Neonatology, North Shore Medical Center, Miami, Florida
  • 2Department of Pediatrics, Section of Neonatology, Christiana Care Health Services, Newark, Delaware
  • 3Thomas Jefferson University Medical College, Philadelphia, Pennsylvania
  • 4Department of Pediatrics, Section of Medical Genetics, duPont Hospital for Children, Wilmington, Delaware
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Oktober 2003 (online)

    Lizenzen und Reprints

ABSTRACT

Transient hypothyroxinemia is common in premature infants and has been associated with intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), poor neurodevelopmental outcomes, and mortality. Recent trials have failed to show that supplemental thyroid hormone improves overall neurodevelopmental outcome. The objective of this article is too determine perinatal risk factors for transient hypothyroxinemia (TH). We studied a cohort of infants born between July 1993 and July 2000 who were less than 1500 g and who received a newborn screening for thyroid function (n = 932). Total serum thyroxine (T4) was collected routinely on the fifth day of life. T4 was correlated with gestational age (R = 0.59, p < 0.01). After controlling for potential confounding variables, gestational age, dopamine, and mechanical ventilation were found to be independently associated with low T4 (overall model: r 2 = 0.41, p < 0.01). Number needed to treat (NNT) analysis showed treating all infants less than 27 weeks would lead to treating 6.3 infants for every one with a subsequent T4 < 5μg/dL. By combining gestational age and need for dopamine support, NNT = 2.4 for every one infant with subsequent T4 < 5μg/dL. Low gestational age, mechanical ventilation, and need for dopamine were associated with low T4 levels and may be helpful in optimizing treatment strategies for TH.

KEYWORDS

Thyroxine - transient hypothyroxinemia - prematurity

REFERENCES

  • 1 Frank J E, Faix J E, Hermos R J. et al . Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening.  J Pediatr . 1996;  128 548-554
    CrossrefPubMedGoogle Scholar
  • 2 Timiras P S, Nzekwe E U. Thyroid hormones and nervous system development.  Biol Neonate . 1989;  55 376-385
    PubMedGoogle Scholar
  • 3 Paul D A, Leef K H, Stefano J L, Bartoshesky L. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants.  Pediatrics . 1998;  101 903-907
    CrossrefPubMedGoogle Scholar
  • 4 Reuss M L, Paneth N, Pinto-Martin J A, Lorenz J M, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.  N Engl J Med . 1996;  334 821-827
    CrossrefPubMedGoogle Scholar
  • 5 Rapaport R, Rose S, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.  J Pediatr . 2001;  139 182-188
    CrossrefPubMedGoogle Scholar
  • 6 Crowther C A, Hiller J E, Haslam R R, Robinson J S. Australian collaborative trial of antenatal thyrotropin-releasing hormone: adverse effects at 12-months follow-up. ACTOBAT Study Group.  Pediatrics . 1997;  99 311-317
    CrossrefPubMedGoogle Scholar
  • 7 van Wassenaer A, Kok J H, de Vijlder J J. et al . Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.  N Engl J Med . 1997;  336 21-26
    CrossrefPubMedGoogle Scholar
  • 8 Ballard J L, Khoury J C, Wedig K, Wang L, Eilers-Walsman B L, Lipp R. New Ballard score, expanded to include extremely premature infants.  J Pediatr . 1991;  119 417-423
    CrossrefPubMedGoogle Scholar
  • 9 Northern Neonatal Nursing Initiative. Systolic blood pressure in babies less than 32 weeks gestation in the first year of life.  Arch Dis Child Fetal Neonatal Ed . 1999;  80 F38-F42
    PubMedGoogle Scholar
  • 10 Paul D A, Leef K L, Voss B, Stefano J L, Bartoshesky L. Thyroxine and illness severity in very low birth weight infants.  Thyroid . 2001;  11 871-875
    CrossrefPubMedGoogle Scholar
  • 11 Uhrmann S, Marks K H, Maisels M J, Kulin H E, Kaplan M, Utiger R. Frequency of transient hypothyroxinemia in low birthweight infants.  Arch Dis Child . 1981;  56 214-217
    PubMedGoogle Scholar
  • 12 Leviton A, Paneth N, Reuss M L. et al . Hypothyroxinemia of prematurity and the risk of cerebral white matter damage.  J Pediatr . 1999;  134 706-711
    CrossrefPubMedGoogle Scholar
  • 13 Marsh T D, Freeman D, McKeown R E, Bowyer F B. Increased mortality in neonates with low thyroxine values.  J Perinatol . 1993;  13 201-204
    PubMedGoogle Scholar
  • 14 Vanhole C, Aerssens P, Naulaers G. L-Thyroxine treatment of preterm newborns: clinical and endocrine effects.  Pediatr Res . 1997;  42 87-92
    CrossrefPubMedGoogle Scholar
  • 15 Chowdry P, Scanlon J W, Auerbach R, Abassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia.  Pediatrics . 1984;  73 301-305
    PubMedGoogle Scholar
  • 16 Briet J, van Wassenaer A, Dekker F W. et al . Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.  Pediatrics . 2001;  107 712-718
    CrossrefPubMedGoogle Scholar
  • 17 Smith L, Leake R, Berman N, Villanueva S, Brasel J. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity.  J Perinatol . 2000;  20 427-431
    CrossrefPubMedGoogle Scholar
      >